We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. Markets closed

Amyris, Inc. (AMRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.67-0.10 (-1.48%)
At close: 4:00PM EDT

6.67 0.00 (0.00%)
After hours: 4:16PM EDT

Full screen
Previous Close6.77
Open6.74
Bid6.60 x 3100
Ask6.74 x 1100
Day's Range6.61 - 6.77
52 Week Range1.86 - 7.30
Volume272,563
Avg. Volume705,828
Market Cap348.359M
Beta-2.30
PE Ratio (TTM)N/A
EPS (TTM)-3.68
Earnings DateAug 8, 2018 - Aug 13, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.50
Trade prices are not sourced from all markets
  • GlobeNewswire2 days ago

    Amyris’s Biossance Brand leads in Clean Beauty with another record quarter; Expands capability and expertise to accelerate growth

    In support of its growth strategy to become a global leader in Clean Beauty, Amyris (AMRS) has announced two executive appointments to ensure it can respond quickly to the surging consumer demand for its Clean Beauty skincare products from Biossance™, now the fastest selling skincare brand in North America. Caroline Hadfield has been promoted to President of Biossance, and is recognized for leading its launch and subsequent success with consumers looking for clean, non-toxic skincare that delivers superior performance.  Formerly Senior Vice President of Personal Care at Amyris, Ms. Hadfield will continue to lead brand positioning, new product and category innovation and development, supply chain management and operations. A leading advocate for the introduction of Clean Beauty in the skincare market, she has successfully established Biossance as a leader in this rapidly growing sector of the market, delivering an outstanding range of Clean Beauty products that meet our No Compromise™ philosophy of safe, non-toxic ingredients that are efficacious and deliver superior performance.

  • ACCESSWIRE7 days ago

    Free Technical Research on Axalta Coating Systems and Three More Specialty Chemicals Equities

    LONDON, UK / ACCESSWIRE / July 11, 2018 / If you want a free Stock Review on AXTA sign up now at www.wallstequities.com/registration. WallStEquities.com has selected the following stocks for review: Aemetis Inc. (NASDAQ: AMTX), Amyris Inc. (NASDAQ: AMRS), Axalta Coating Systems Ltd (NYSE: AXTA), and Ecolab Inc. (NYSE: ECL).

  • GlobeNewswire16 days ago

    Amyris Announces Non-Dilutive $36 Million Term Loan to Pay Off Stegodon and Other Short-Term Debt Maturities

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, announces that it has closed on a $36 million term loan with Great American Capital Partners, LLC ("GACP"), a subsidiary of B. Riley Capital Management, LLC, an SEC Registered Investment Advisor and wholly-owned subsidiary of B. Riley Financial, Inc. Cash from the term loan will be used to pay off the company’s Stegodon and other short-term debt maturities. The term loan also includes an additional $35 million accordion credit facility that provides Amyris with another option for financing construction of its production facility, if necessary.

  • GlobeNewswire21 days ago

    Amyris Expands Production Contract with ADL BioPharma Due to Demand Growth

    Amyris is disrupting markets by using the most advanced science and technology, including machine-learning and robotics to program yeast to create targeted molecules, at a lower cost and with sustainable supplies, resulting in sustainable methods of materials production. Amyris is the only company in the sector that has production capability at industrial scale, is evidenced by its clean manufacturing and commercialization of 15 products and its established supply agreements with market leaders across a range of business segments. Amyris is now expanding its production contract with ADL in order to provide additional, cost-effective manufacturing capability to meet the higher than expected demands from its partners.

  • GlobeNewswire22 days ago

    Amyris and BGI Agree to Joint Venture to Develop Products to Improve Human Health in Greater China

    Amyris, Inc. (AMRS), a leader in the development and production of sustainable, fermentation-derived ingredients in the markets of Health & Wellness, Clean Beauty and Flavors & Fragrances announces that it plans to partner with BGI, the world’s largest genomics company. The companies intend to apply their synthetic biology platforms in a new joint venture to discover, develop and commercialize human microbiome-targeting health and nutrition products in Greater China. The joint venture seeks to combine Amyris’s best-in-class science and technology with BGI’s gene sequencing expertise, data and analytics.

  • GlobeNewswirelast month

    Amyris Announces Signing of Major UCP in Porto/AICEP Consortium Project Agreement Valued at $50 Million

    Amyris, Inc. (AMRS), the industrial bioscience company, today announced that it has executed an agreement for a significant project consortium in Europe with the Universidade Católica Portuguesa (UCP) Porto Campus and AICEP Portugal Global (AICEP). UCP is a university system, including the leading biotech school in Portugal, and operates 15 research centers. AICEP is an independent public entity of the Government of Portugal, focused in encouraging the best foreign companies to invest in Portugal.

  • GlobeNewswirelast month

    Amyris Set to Join Russell Microcap® Index

    Amyris, Inc. (AMRS), the industrial bioscience company, today announced that it is set to join the Russell Microcap® Index at the conclusion of the Russell US Indexes annual reconstitution, effective after the US market opens on June 25, according to a preliminary list of additions posted June 8. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell US Indexes primarily by objective, market-capitalization rankings and style attributes.

  • Why Amyris (AMRS) Could Be Positioned for a Slump
    Zackslast month

    Why Amyris (AMRS) Could Be Positioned for a Slump

    Amyris (AMRS) is one stock you should avoid as it has seen a significant price decline and is also seeing negative earnings estimate revisions.

  • New Strong Sell Stocks for June 4th
    Zackslast month

    New Strong Sell Stocks for June 4th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • ACCESSWIRE2 months ago

    Today’s Free Research Reports Coverage on Axalta Coating Systems and Three More Specialty Chemicals Stocks

    LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want a free Stock Review on AXTA sign up now at www.wallstequities.com/registration. Lined up for evaluation this morning are these four stocks: Aemetis Inc. (NASDAQ: AMTX), Amyris Inc. (NASDAQ: AMRS), Axalta Coating Systems Ltd (NYSE: AXTA), and Ecolab Inc. (NYSE: ECL).